New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Friday, Nov 20, 2026
Export SBRA’s income statement to Excel — free account
Sabra Healthcare REIT, Inc.
SBRAReal Estate Reit Healthcare Facilities
Sabra Healthcare REIT, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $774.6 million, up 10.2% from fiscal 2024.
- Revenue
- +31.3%
- EPS
- +22.2%
- Free cash flow
- n/m
- Total debt
- −5.99%
Quarter to September 2026, against a year earlier
20.39
0.07
−0.34%
After hours trading: 20.39, unchanged, last trade 4:01pm Eastern.
Follow SBRA
Alert me
Analysts’ price targets Wall Street, collected weekly
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 261 | 408 | 623 | 662 | 599 | 570 | 625 | 648 | 703 | 775 | 919 | +12.9% | 865 | 998 | 1,097 | +12.3% | |
| Gross margin, % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 0.0 pt | ||||||
| EBT | 71 | 159 | 288 | 79 | 156 | 81 | 22 | 19 | 128 | 153 | 65 | +8.9% | ||||||
| EBT margin, % | 27.35 | 38.95 | 46.13 | 11.97 | 26.02 | 14.16 | 3.47 | 2.88 | 18.22 | 19.81 | 7.07 | (7.5) pt | ||||||
| Net income | 70 | 158 | 279 | 69 | 138 | (113) | (78) | 14 | 127 | 156 | 71 | +9.2% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 3.99 | 3.87 | 3.50 | 3.54 | 2.90 | 2.60 | 2.71 | 2.80 | 3.01 | 3.21 | 3.60 | (2.4%) | |||||
| Earnings | 0.92 | 1.40 | 1.51 | 0.37 | 0.67 | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 | 0.28 | (4.0%) | ||||||
| Cash flow | 2.69 | 1.29 | 2.02 | 1.99 | 1.72 | 1.63 | 1.37 | 1.30 | 1.33 | 1.44 | 1.57 | (6.7%) | ||||||
| Capex | (0.87) | (2.62) | 0.52 | 1.35 | (0.60) | (0.19) | (0.26) | 0.36 | (0.41) | (1.68) | (2.49) | +7.6% | ||||||
| Free cash flow | 1.83 | (1.33) | 2.55 | 3.34 | 1.12 | 1.44 | 1.11 | 1.66 | 0.92 | (0.24) | (0.93) | n/m | ||||||
| Book value | 15.56 | 32.54 | 18.25 | 18.64 | 16.53 | 15.43 | 13.23 | 12.12 | 11.74 | 11.70 | 11.12 | (3.1%) | ||||||
| Shares, m | 65 | 106 | 178 | 187 | 206 | 219 | 231 | 231 | 233 | 241 | 250 | +15.6% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 26.76 | 13.70 | 10.84 | 62.76 | 25.93 | n/m | n/m | 283.80 | 32.07 | 29.14 | 72.82 | 60.6 | |||||
| P/S | 6.17 | 4.94 | 4.71 | 6.04 | 5.98 | 5.21 | 4.66 | 5.07 | 5.75 | 5.90 | 5.67 | 5.4 | ||||||
| P/B | 1.58 | 0.59 | 0.90 | 1.15 | 1.05 | 0.88 | 0.95 | 1.17 | 1.48 | 1.62 | 1.83 | 1.1 | ||||||
| EV/Sales | 10.68 | 11.81 | 9.80 | 9.59 | 9.84 | 9.21 | 8.59 | 8.72 | 9.09 | 9.06 | 8.27 | 9.6 | ||||||
| EV/FCF | 23.32 | (34.25) | 13.46 | 10.16 | 25.46 | 16.65 | 20.93 | 14.68 | 29.69 | (122.74) | (32.10) | (0.3) | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | 176 | 136 | 361 | 372 | 355 | 356 | 316 | 301 | 311 | 349 | 401 | +7.9% | |||||
| Capex | (57) | (277) | 93 | 252 | (124) | (41) | (59) | 84 | (95) | (406) | (637) | +24.5% | ||||||
| Free cash flow | 119 | (141) | 454 | 625 | 231 | 315 | 256 | 385 | 215 | (57) | (237) | n/m | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 91 | 599 | 79 | 48 | 22 | 372 | 323 | 330 | 391 | 393 | 28 | +17.6% | |||||
| Net debt | 1,176 | 2,807 | 3,172 | 2,353 | 2,307 | 2,279 | 2,453 | 2,367 | 2,351 | 2,451 | 2,393 | +8.5% | ||||||
| Shareholders’ equity | 1,016 | 3,437 | 3,255 | 3,488 | 3,409 | 3,380 | 3,056 | 2,803 | 2,741 | 2,824 | 2,841 | +12.0% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | 2.54 | 3.19 | 3.93 | 1.08 | 2.30 | (1.90) | (1.32) | 0.25 | 2.37 | 2.88 | 1.30 | +0.3 pt | |||||
| ROIC | 3.77 | 1.96 | 2.97 | 2.33 | 2.75 | 2.22 | 1.60 | 2.50 | 2.93 | 3.04 | 1.95 | (0.7) pt | ||||||
| ROE | 5.80 | 6.65 | 8.05 | 2.05 | 4.01 | (3.34) | (2.41) | 0.47 | 4.57 | 5.59 | 2.52 | (0.2) pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 14 | 61 | 31 | 34 | 38 | 42 | 42 | 48 | 50 | 58 | — | +17.1% | |||||
| Revenue/emp, $m | 18.61 | 6.69 | 20.11 | 19.46 | 15.75 | 13.56 | 14.88 | 13.49 | 14.06 | 13.36 | — | (3.6%) | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated Nov 18, 2026
Sabra Healthcare REIT, Inc. vs peers in Reit Healthcare Facilities (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| OHI Omega Healthcare Investors, Inc. | $14.0B | 18.2× | 19.4× FY26e | +9.30% (above 0%: growing) | −54.24% (below 0%: shrinking) | −1,060.46% (below 0%: shrinking) | 100.00% | 35.62% | Compare |
| DOC Healthpeak Properties, Inc. | $13.6B | 35.6× | 48.3× FY26e | +16.29% (above 0%: growing) | n/m | −1,493.36% (below 0%: shrinking) | 53.78% | 13.33% | Compare |
| AHR American Healthcare REIT, Inc. | $13.5B | 117× | 89.0× FY26e | +29.53% (above 0%: growing) | −57.58% (below 0%: shrinking) | +19.47% (above 0%: growing) | 22.21% | 6.36% | Compare |
| CTRE CareTrust REIT, Inc. | $9.5B | 23.1× | 24.9× FY26e | +33.16% (above 0%: growing) | 0.00% | −2,473.98% (below 0%: shrinking) | 98.38% | 62.35% | Compare |
| HR Healthcare Realty Trust Incorporated | $6.6B | — (loss-making) | — (loss-making) | −3.74% (below 0%: shrinking) | n/m | −65.19% (below 0%: shrinking) | 64.26% | 14.64% | Compare |
| SBRA Sabra Healthcare REIT, Inc. | $5.4B | 72.8× | 62.6× FY26e | +31.32% (above 0%: growing) | +22.22% (above 0%: growing) | +26.70% (above 0%: growing) | 100.00% | 25.59% | |
| NHI National Health Investors, Inc. | $3.0B | 4.3× | 4.5× FY26e | +26.31% (above 0%: growing) | +1,564.39% (above 0%: growing) | +782.13% (above 0%: growing) | 68.11% | 26.23% | Compare |
| LTC LTC Properties, Inc. | $2.4B | 4.4× | 5.4× FY26e | +66.32% (above 0%: growing) | n/m | −126.46% (below 0%: shrinking) | 100.00% | 303.46% | Compare |
| DHC Diversified Healthcare Trust | $1.7B | — (loss-making) | — (loss-making) | −5.41% (below 0%: shrinking) | n/m | +100.70% (above 0%: growing) | 21.97% | (3.97%) | Compare |
| Median of peers | $8.0B | 20.7× | 22.2× | +21.30% | −27.12% | −95.82% | 66.19% | 20.43% |
Pay and ownership Proxy statement filed Apr 24, 2026
Chief executive’s pay
| Year | Total pay | Actually paid | $100 invested |
|---|---|---|---|
| 2025 | 8.55m | 12.70m | — |
| 2024 | 8.48m | 14.34m | — |
| 2023 | 8.22m | 12.21m | — |
| 2022 | 6.65m | 7.29m | — |
| 2021 | 6.09m | 1.13m | — |
Ownership
Directors and executive officers, together
1.09%
BlackRock, Inc.
13.67%
The Vanguard Group, Inc.
13.54%
Principal Real Estate Investors LLC
8.46%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards
at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s
shares at the start of the earliest year shown was worth at each year’s end.
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement
Sabra Healthcare REIT, Inc. (SBRA) Latest News
- Sabra Health Care REIT, Inc. Q3 2026 Earnings Call Summary Moby
- Sabra Issues Business Update and Increases Full-Year 2026 Guidance
- A Look At Sabra Health Care REIT (SBRA) Valuation After Q1 Results And Senior Housing Shift Simply Wall St.
- Should Sabra’s Senior Housing Pivot and Private Pay Mix Shift Require Action From Sabra Health Care REIT (SBRA) Investors? Simply Wall St.
- Sabra Health Care REIT Inc (SBRA) Q1 2026 Earnings Call Highlights: Strong Growth in Senior ... GuruFocus.com
- Sabra Healthcare REIT Q1 Earnings Call Highlights MarketBeat
- Sabra (SBRA) Q1 2026 Earnings Transcript The Motley Fool transcript
- Sabra Healthcare (SBRA) Tops Q1 FFO and Revenue Estimates Zacks
- How The Story Around Sabra Health Care REIT (SBRA) Is Evolving After Q4 And 2026 Guidance Simply Wall St.
- Why Sabra Health Care REIT (SBRA) Is Up 6.0% After 2025 Earnings And 2026 Dividend Guidance Simply Wall St.
20 more headlines
- Sabra Health Care: 3 Key Takeaways for Long-Term Investors The Motley Fool
- Sabra Health Care REIT Inc (SBRA) (Q3 2026) Earnings Call Highlights: Strong SHOP Growth and ... GuruFocus.com
- What Sabra Healthcare REIT (SBRA) Said on Its Q3 Earnings Call MarketBeat transcript
- Sabra Health (SBRA) Q3 2026 Earnings Call Transcript The Motley Fool transcript
- Sabra Reports Third Quarter 2026 Results; Updates 2026 Guidance Business Wire
- Medical Properties Trust Sinks 13% as FFO Misses and Tenant Troubles “Precluded Payment of September Rent” TIKR
- What Is Behind The Move In Welltower Stock? Trefis
- Sabra Health Care REIT (SBRA) Q2 2026 Earnings Call Transcript The Motley Fool transcript
- Sabra Health Care REIT Inc (SBRA) (Q2 2026) Earnings Call Highlights: Strong Senior Housing ... transcript
- Sabra Healthcare REIT Q2 Earnings Call Highlights MarketBeat transcript
- Sabra Health Care REIT, Inc. Q2 2026 Earnings Call Summary Moby transcript
- Sabra Healthcare (SBRA) Tops Q2 FFO and Revenue Estimates
- Sabra Reports Second Quarter 2026 Results; Reiterates 2026 Guidance
- Why Sabra Health Care REIT Stock Soared Today The Motley Fool
- Better Senior Housing REIT: Sabra Health Care or Welltower? The Motley Fool
- How The Sabra Health Care REIT (SBRA) Investment Story Is Evolving With Recent Updates Simply Wall St.
- Sabra Health Care REIT, Inc. Q1 2026 Earnings Call Summary Moby
- Sabra Reports First Quarter 2026 Results; Reiterates 2026 Guidance Business Wire
- Most Retirees Are Overlooking This 8.5% Dividend ETF’s Hidden Safety Issue 24/7 Wall St.
- Sabra Health Care REIT Inc (SBRA) Q4 2025 Earnings Call Highlights: Strong Senior Housing ... GuruFocus.com transcript
SBRA metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score